IGC Pharma (IGC) EPS (Weighted Average and Diluted) (2010 - 2025)
IGC Pharma (IGC) reported EPS (Weighted Average and Diluted) of -$0.02 for Q3 2025, little changed year-over-year from -$0.02 in Q3 2024, and little changed quarter-over-quarter from -$0.02 in Q2 2025.
IGC Pharma (IGC) EPS (Weighted Average and Diluted) (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 11 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.02 in Q3 2025.
- EPS (Weighted Average and Diluted) for Q3 2025 came in at -$0.02, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.03 (up 61.29% YoY), and the FY2026 annual result was -$0.02, up 77.78% from the prior year.
- EPS (Weighted Average and Diluted) was little changed at -$0.02 in Q3 2025 per IGC's latest filing, from -$0.02 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.02 in Q3 2024 and troughed at -$0.09 in Q4 2023.
- A 3-year average of -$0.03 and a median of -$0.02 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) soared 77.78% in 2024, then changed 0.0% in 2025.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2023, then jumped by 77.78% to -$0.02 in 2024, then changed by 0.0% to -$0.02 in 2025.
- Business Quant data shows IGC's EPS (Weighted Average and Diluted) at -$0.02 in Q3 2025, -$0.02 in Q2 2025, and -$0.02 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.04 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.05 |
| Dec 31, 2017 | -0.02 |
| Sep 30, 2017 | -0.01 |
| Jun 30, 2017 | -0.02 |
| Mar 31, 2017 | -0.03 |
| Dec 31, 2016 | -0.01 |
| Sep 30, 2016 | -0.02 |
| Jun 30, 2016 | -0.02 |
| Mar 31, 2016 | -0.08 |
| Dec 31, 2015 | -0.02 |
| Sep 30, 2015 | -0.04 |
| Jun 30, 2015 | -0.03 |